These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36300706)

  • 41. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.
    Kuznik A; Habib AG; Munube D; Lamorde M
    BMC Health Serv Res; 2016 Jul; 16():304. PubMed ID: 27461265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
    Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
    East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.
    Nguyen-Khoa T; Mine L; Allaf B; Ribeil JA; Remus C; Stanislas A; Gauthereau V; Enouz S; Kim JS; Yang X; Gluckman E; Beaudeux JL; Munnich A; Girot R; Cavazzana M
    Ann Biol Clin (Paris); 2018 Aug; 76(4):416-420. PubMed ID: 29976532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sickle cell disease in children.
    Meier ER; Miller JL
    Drugs; 2012 May; 72(7):895-906. PubMed ID: 22519940
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sickle solubility test to screen for sickle cell trait: what's the harm?
    Tubman VN; Field JJ
    Hematology Am Soc Hematol Educ Program; 2015; 2015():433-5. PubMed ID: 26637754
    [No Abstract]   [Full Text] [Related]  

  • 46. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
    Colombatti R; Martella M; Cattaneo L; Viola G; Cappellari A; Bergamo C; Azzena S; Schiavon S; Baraldi E; Dalla Barba B; Trafojer U; Corti P; Uggeri M; Tagliabue PE; Zorloni C; Bracchi M; Biondi A; Basso G; Masera N; Sainati L
    Pediatr Blood Cancer; 2019 May; 66(5):e27657. PubMed ID: 30724025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mortality among children with sickle cell disease identified by newborn screening during 1990-1994--California, Illinois, and New York.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(9):169-72. PubMed ID: 9518280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The increasing prevalence of childhood sickle-cell disease in Ireland.
    McMahon C; Callaghan CO; O'Brien D; Smith OP
    Ir J Med Sci; 2001; 170(3):183-5. PubMed ID: 12120971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is universal neonatal hemoglobinopathy screening cost-effective?
    Bergman AB
    Arch Pediatr Adolesc Med; 1995 Apr; 149(4):466-7. PubMed ID: 7704180
    [No Abstract]   [Full Text] [Related]  

  • 50. Acute care utilization in pediatric sickle cell disease and sickle cell trait in the USA: prevalence, temporal trends, and cost.
    Peterson EE; Salemi JL; Dongarwar D; Salihu HM
    Eur J Pediatr; 2020 Nov; 179(11):1701-1710. PubMed ID: 32394268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
    Nnodu OE; Sopekan A; Nnebe-Agumadu U; Ohiaeri C; Adeniran A; Shedul G; Isa HA; Owolabi O; Chianumba RI; Tanko Y; Iyobosa JH; Adekile AD; Olopade OI; Piel FB
    Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experience of a sickle cell screening program in Baltimore.
    Miller JM; Davis DC
    J Natl Med Assoc; 1979 Sep; 71(9):839-41. PubMed ID: 501751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of thalassaemia and haemoglobin S syndromes in Greece.
    Fessas P
    Acta Haematol; 1987; 78(2-3):168-72. PubMed ID: 3120466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
    Moat SJ; Rees D; King L; Ifederu A; Harvey K; Hall K; Lloyd G; Morrell C; Hillier S
    Clin Chem; 2014 Feb; 60(2):373-80. PubMed ID: 24158758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effort required to contact primary care providers after newborn screening identifies sickle cell trait.
    Christopher SA; Collins JL; Farrell MH
    J Natl Med Assoc; 2012; 104(11-12):528-34. PubMed ID: 23560355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy.
    Ballardini E; Tarocco A; Marsella M; Bernardoni R; Carandina G; Melandri C; Guerra G; Patella A; Zucchelli M; Ferlini A; Bigoni S; Ravani A; Garani G; Borgna-Pignatti C
    Blood Transfus; 2013 Apr; 11(2):245-9. PubMed ID: 23058858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sickle cell.
    Whitten CF; Whitten-Shurney W
    Clin Perinatol; 2001 Jun; 28(2):435-48. PubMed ID: 11499064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sickle cell disease in childhood: from newborn screening through transition to adult medical care.
    Quinn CT
    Pediatr Clin North Am; 2013 Dec; 60(6):1363-81. PubMed ID: 24237976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strategy linking several analytical methods of neonatal screening for sickle cell disease.
    Ducrocq R; Pascaud O; Bévier A; Finet C; Benkerrou M; Elion J
    J Med Screen; 2001; 8(1):8-14. PubMed ID: 11373853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neonatal screening for sickle cell disease in the Eastern Province of Saudi Arabia.
    Al-Awamy BH; Al-Muzan M; Al-Turki M; Serjeant GR
    Trans R Soc Trop Med Hyg; 1984; 78(6):792-4. PubMed ID: 6533853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.